Molecule for functionalizing a support, attachment of a radionuclide to the support and radionuclide generator for preparing the radionuclide, and preparation process

09802969 · 2017-10-31

Assignee

Inventors

Cpc classification

International classification

Abstract

Molecule for attaching a radioactive parent nuclide to a support, comprising at least one functional group for attaching the radioactive parent nuclide; and a molecular moiety suitable for establishing a nonpolar bond to the support.

Claims

1. An organic or inorganic support for use as stationary phase, the support comprising: resin or silica gel, and a compound comprising: pyrogallol or catechol, and a saturated or unsaturated fatty acid having more than 3 carbon atoms, or a branched or straight-chain alkyl chain having more than 3 carbon atoms.

2. The support of claim 1, where the branched or straight-chain alkyl chain having more than 3 carbon atoms is one of an octyl, decyl or octadecyl group.

3. The support of claim 1, where the compound is dodecyl 3,4,5-trihydroxybenzoate or 2,3-dihydroxynaphthalene.

4. The support of claim 1, where the support is coated with the compound.

Description

(1) FIGS. 1a, b show the structural formulae of catechol (FIG. 1a) and pyrogallol as compounds having germanium-specific functional groups;

(2) FIGS. 2a, b show the structural formulae of examples of molecules according to the invention such as 2,3-dihydroxynaphthalene (FIG. 2a) and dodecyl 3,4,5-trihydroxybenzoate.

EXAMPLE

(3) A germanium-specific resin was prepared by coating inert silica gel with dodecyl 3,4,5-trihydroxybenzoate having the structural formula shown in FIG. 1b. The resin was used for preparing small chromatographic columns. An aqueous solution comprising the radio-nuclide germanium-68 having an activity in the range between 20 and 1250 MBq was then pumped through the columns. During this step, the germanium-68 was adsorbed quantitatively on the columns.

(4) The columns charged with germanium-68 were then used to prepare the short-lived gallium-68. It was possible to repeatedly eluate the gallium-68 generated by the germanium-68 absorbed on the support. The elution of gallium-68 was effected using weak hydrochloric acid solutions (0.05 M HCl) having a low volume of up to 2.5 ml. Leakage of the parent nuclide germanium-68 was in the range 1×10.sup.−4−3×10.sup.−3%. The gallium-68 could be used directly and without further chemical reprocessing for preparing injectable gallium-68 radio-pharmaceutics.

LITERATURE REFERENCES

(5) 1) Al-Nahhas A, Win Z, Szysko T, Singha A, Nannil C, Fanti S, Rubello D. Gallium-68 PET: A New Frontier in Receptor Cancer Imaging. Anticancer research. 2007; 27: 4087-4094 2) Helmut M, Hofmann M, Haberkorn U. .sup.68Ga-Labeled Peptides in Tumor Imaging. J Nuc Med. 2005; 46: 172S-178S 3) Breeman W, Jong M, Blois E, Bernard B, Konijnenberg M, Krenning E. Radiolabelling DOTA-peptides with .sup.68Ga. Eur J Nuc Med Mol Imaging. 2005; 32: 478-458 4) Meyer G-J, Mäcke H, Schuhmacher J, Knapp W, Hofmann M. .sup.68Ga-labelled DOTA-derivatised peptide ligands. Eur J Nuc Med Mol Imaging. 2004; 31: 1097-1104 5) Zhernosekov K, Filosofov D, Baum R, Aschoff P, Bihl H, Razbash A, Jahn M, Jennewein M, Rösch F. Processing of generator-produced .sup.68Ga for medical application. J Nuc Med. 2007; 48: 1741-1748 6) Patent DE 29 32 948 A1 7) Schuhmacher J, Maier-Borst W. A new .sup.68Ge/.sup.68Ga radio-isotope generator system for production of .sup.68Ga in dilute HCl. I J Appl Rad Isotopes. 1981; 32: 31-36